» Articles » PMID: 23873904

MDCT Features in the Differentiation of T4a Gastric Cancer from Less-advanced Gastric Cancer: Significance of the Hyperattenuating Serosa Sign

Overview
Journal Br J Radiol
Specialty Radiology
Date 2013 Jul 23
PMID 23873904
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of our study was to evaluate CT findings to differentiate between T4a and less advanced gastric cancers.

Methods: The institutional review board approved this study and waived informed consent. This study included 228 retrospectively identified patients with surgically confirmed gastric cancer (138 T1, 25 T2, 24 T3 and 41 T4a) and who had also undergone pre-operative CT scan. Transverse and multiplanar reconstruction scans were reviewed in consensus by two other blinded radiologists. The following CT findings that differentiate T4a from less advanced cancers were evaluated: nodular or an irregular outer layer of the gastric wall, haziness of the perigastric fat and a hyperattenuating serosa sign. The CT features of T4a and less advanced gastric cancers were compared by means of univariate and multivariate analyses.

Results: In univariate analysis, nodular or an irregular outer layer of the gastric wall, haziness of the perigastric fat and the hyperattenuating serosa sign were significant in differentiation between T4a and less advanced gastric cancers. In addition, nodular or an irregular outer layer of the gastric wall and the hyperattenuating serosa sign were significant in differentiation between T3 and T4a. In multivariate logistic analysis, the hyperattenuating serosa sign was the most significant finding in differentiation between T3 and T4a (odds ratio, 4.210; 95% confidence intervals, 1.581-11.214; p=0.004).

Conclusion: The hyperattenuating serosa sign may be a useful CT finding in differentiation between T4a and less-advanced gastric cancers.

Advances In Knowledge: The hyperattenuating serosa sign is associated with gastric cancer with invading the serosa and can facilitate planning of the optimal pre-operative evaluation and treatment.

Citing Articles

Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial.

Gan X, Jia Y, Shan F, Ying X, Li S, Zhang Y BMC Cancer. 2025; 25(1):401.

PMID: 40045265 PMC: 11884205. DOI: 10.1186/s12885-024-13372-6.


Influence of visceral adipose tissue on the accuracy of tumor T-staging of gastric cancer in preoperative CT.

Wu D, Bian L, Wang Z, Ni J, Chen Y, Zhang L Jpn J Radiol. 2024; .

PMID: 39607533 DOI: 10.1007/s11604-024-01711-3.


Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.

Chen Y, Chen X, Lin Y, Zhang S, Zhou Z, Peng J BMC Cancer. 2024; 24(1):255.

PMID: 38395845 PMC: 10885455. DOI: 10.1186/s12885-024-11993-5.


The 'double‑track sign': A novel CT finding suggestive of the diagnosis of T1a gastric cancer.

Liang P, Lv D, Ren X, Cheng M, Hu Z, Yong L Oncol Lett. 2023; 26(1):286.

PMID: 37274467 PMC: 10236118. DOI: 10.3892/ol.2023.13872.


Added Value of the Sliding Sign on Right Down Decubitus CT for Determining Adjacent Organ Invasion in Patients with Advanced Gastric Cancer.

Jeon K, Kim S, Yoo J, Kim S J Korean Soc Radiol. 2022; 83(6):1312-1326.

PMID: 36545416 PMC: 9748461. DOI: 10.3348/jksr.2021.0166.


References
1.
Badgwell B, Cormier J, Krishnan S, Yao J, Staerkel G, Lupo P . Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?. Ann Surg Oncol. 2008; 15(10):2684-91. DOI: 10.1245/s10434-008-0055-3. View

2.
Roviello F, Marrelli D, De Manzoni G, Morgagni P, Di Leo A, Saragoni L . Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003; 90(9):1113-9. DOI: 10.1002/bjs.4164. View

3.
Jatzko G, Lisborg P, Denk H, Klimpfinger M, Stettner H . A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer. 1995; 76(8):1302-12. DOI: 10.1002/1097-0142(19951015)76:8<1302::aid-cncr2820760803>3.0.co;2-8. View

4.
Adachi Y, Mori M, Enjoji M, Sugimachi K . Microvascular architecture of early gastric carcinoma. Microvascular-histopathologic correlates. Cancer. 1993; 72(1):32-6. DOI: 10.1002/1097-0142(19930701)72:1<32::aid-cncr2820720108>3.0.co;2-6. View

5.
Kamangar F, Dores G, Anderson W . Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24(14):2137-50. DOI: 10.1200/JCO.2005.05.2308. View